RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: parasitic protozoa infectious disease
Accession: DOID:2789
browse the term
Definition: A parasitic infectious disease that is caused by parasitic protozoa which are microorganisms classified as unicellular eukaryotes. (DO)
Synonyms: exact_synonym: Histomoniasis; Protozoan Infection; histomoniases; mastigophora infectious disease; protozoan infections; sarcomastigophora infectious disease
primary_id: MESH:D011528
xref: ICD10CM:B64 ; NCI:C34953
For additional species annotation, visit the
Alliance of Genome Resources .
G
TLR4
toll like receptor 4
ISO
mRNA,protein:increased expression:cornea
RGD
PMID:21155840
RGD:7777095
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
IL2
interleukin 2
treatment
ISO
RGD
PMID:10862314
RGD:14928216
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:26809113
RGD:39458041
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism, haplotype: :HLA-DQB1*04, HLA-DQB1*02
RGD
PMID:25938667
RGD:36049810
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
TNF
tumor necrosis factor
treatment
ISO
RGD
PMID:10862314
RGD:14928216
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
IL25
interleukin 25
ISO
protein:decreased expression:intestine
RGD
PMID:28246365
RGD:39128243
NCBI chr14:4,191,888...4,195,043
Ensembl chr14:22,286,347...22,289,498
G
CCL5
C-C motif chemokine ligand 5
ISO
mRNA, protein:increased expression:blood vessel endothelial cell
RGD
PMID:15710456
RGD:2307183
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:19741601
RGD:8661685
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
FOXP3
forkhead box P3
ISO
mRNA:decreased expression:placenta:
RGD
PMID:21923716
RGD:38501105
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
G
HSPD1
heat shock protein family D (Hsp60) member 1
ISO
RGD
PMID:8881756
RGD:12910478
NCBI chr2B:84,729,615...84,743,352
Ensembl chr2B:202,623,497...202,636,959
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:31231617
RGD:39939039
NCBI chr 8:39,108,310...39,123,611
Ensembl chr 8:36,617,312...36,632,352
G
IL17A
interleukin 17A
ISO
mRNA,protein:increased expression:placenta:
RGD
PMID:21923716
RGD:38501105
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL21
interleukin 21
ISO
RGD
PMID:23667536
RGD:127285360
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:15265921
RGD:39457943
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
IL2RB
interleukin 2 receptor subunit beta
ameliorates
ISO
RGD
PMID:11286020
RGD:42724468
NCBI chr22:18,039,469...18,069,952
Ensembl chr22:35,874,898...35,899,038
G
IL6
interleukin 6
ISO
mRNA:increased expression:placenta:
RGD
PMID:21923716
RGD:38501105
NCBI chr 7:23,415,922...23,420,767
G
LDLR
low density lipoprotein receptor
ISO
RGD
PMID:18316222
RGD:5490254
NCBI chr19:10,640,225...10,683,728
Ensembl chr19:11,357,311...11,396,791
G
NR4A2
nuclear receptor subfamily 4 group A member 2
ISO
RGD
PMID:25855987
RGD:11057198
NCBI chr2B:43,584,835...43,593,118
Ensembl chr2B:160,826,091...160,837,162
G
RORC
RAR related orphan receptor C
ISO
mRNA:increased expression:placenta:
RGD
PMID:21923716
RGD:38501105
NCBI chr 1:127,164,725...127,190,479
Ensembl chr 1:130,808,705...130,834,490
G
STING1
stimulator of interferon response cGAMP interactor 1
severity
ISO
RGD
PMID:31416833
RGD:39128220
NCBI chr 5:134,845,689...134,852,938
Ensembl chr 5:140,967,399...140,973,846
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:decreased expression:serum (human)
RGD
PMID:25539588
RGD:11541121
NCBI chr17:58,417,134...58,526,409
Ensembl chr17:63,511,784...63,579,067
G
C3
complement C3
ISO
protein:increased expression:serum
RGD
PMID:3361150
RGD:11041575
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CFB
complement factor B
ISO
protein:increased expression:serum
RGD
PMID:3361150
RGD:11041575
NCBI chr 6:31,606,716...31,612,782
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
RGD
PMID:14507644
RGD:5135450
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
G
CXCL9
C-X-C motif chemokine ligand 9
ISO
RGD
PMID:14507644
RGD:5135450
NCBI chr 4:48,198,478...48,204,658
Ensembl chr 4:54,036,342...54,042,502
G
ACE2
angiotensin converting enzyme 2
susceptibility
ISO
DNA:SNP:intron 1: C>T
RGD
PMID:20117248
RGD:40818420
NCBI chr X:8,189,267...8,229,415
Ensembl chr X:15,470,896...15,510,891
G
AQP4
aquaporin 4
disease_progression
ISO
protein:increased expression:astrocyte:
RGD
PMID:21904632
RGD:8698661
NCBI chr18:20,108,607...20,122,381
Ensembl chr18:23,713,146...23,726,919
G
CAST
calpastatin
ISO
protein:increased express:brain
RGD
PMID:16236382
RGD:5509817
NCBI chr 5:91,972,572...92,084,657
Ensembl chr 5:97,527,071...97,636,650
G
CD36
CD36 molecule
ISO
RGD
PMID:17367535
RGD:6893527
NCBI chr 7:72,566,478...72,643,517
Ensembl chr 7:86,265,114...86,305,865
G
CLEC12A
C-type lectin domain family 12 member A
ameliorates
ISO
RGD
PMID:31269448
RGD:41412201
NCBI chr12:9,999,334...10,056,108
Ensembl chr12:10,248,209...10,272,070
G
IL33
interleukin 33
treatment
ISO
protein:increased expression:brain
RGD
PMID:25659095 PMID:25682948
RGD:39938955 RGD:40400741
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
G
JAK3
Janus kinase 3
ISO
RGD
PMID:22363534
RGD:11531103
NCBI chr19:17,299,129...17,330,700
Ensembl chr19:18,283,560...18,300,964
G
LTA
lymphotoxin alpha
ISO
RGD
PMID:12021316
RGD:10449455
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
NRG1
neuregulin 1
treatment
ISO
mRNA, protein:increased expression:cerebral cortex (mouse) human protein in a mouse model
RGD
PMID:24433482 PMID:29636063
RGD:39456084 RGD:39456102
NCBI chr 8:30,954,852...32,084,411
Ensembl chr 8:29,050,222...29,263,977
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
RGD
PMID:25775137
RGD:38599200
NCBI chr 7:98,841,974...98,885,446
Ensembl chr 7:111,570,148...111,611,614
G
PRKAA2
protein kinase AMP-activated catalytic subunit alpha 2
ISO
mRNA:decreased expression:brain (mouse)
RGD
PMID:29107705
RGD:39456137
NCBI chr 1:55,928,577...55,998,628
Ensembl chr 1:57,664,237...57,702,227
G
TNFRSF1B
TNF receptor superfamily member 1B
ISO
RGD
PMID:12228317
RGD:5131158
NCBI chr 1:10,915,743...10,957,765
Ensembl chr 1:12,130,663...12,172,646
G
NFKB1
nuclear factor kappa B subunit 1
severity
ISO
RGD
PMID:20156658
RGD:40902838
NCBI chr 4:94,925,048...95,040,849
Ensembl chr 4:105,589,062...105,704,098
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression
ISO
DNA:SNP:promoter:g.-251A>T (rs4073) (human)
RGD
PMID:22537745
RGD:39939013
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
IL10
interleukin 10
treatment
ISO
RGD
PMID:24055715
RGD:7364866
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:28356392
RGD:39457935
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
MBL2
mannose binding lectin 2
severity
ISO
RGD
PMID:26745156
RGD:11076757
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
PCNA
proliferating cell nuclear antigen
ISO
protein:increased expression:myocardium:
RGD
PMID:12435130
RGD:10448990
NCBI chr20:5,134,930...5,146,603
Ensembl chr20:4,927,731...4,939,440
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
disease_progression
ISO
mRNA:increased expression:heart (mouse) mRNA:increased expression:heart (human)
RGD
PMID:29666415
RGD:38599151
NCBI chr 7:98,841,974...98,885,446
Ensembl chr 7:111,570,148...111,611,614
G
CCL2
C-C motif chemokine ligand 2
ISO
RGD
PMID:16844401
RGD:2307145
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCL5
C-C motif chemokine ligand 5
ISO
RGD
PMID:20452453
RGD:4889906
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CHRM2
cholinergic receptor muscarinic 2
ISO
RGD
PMID:9148906
RGD:5509585
NCBI chr 7:128,827,089...128,978,496
Ensembl chr 7:141,466,396...141,467,796
G
F2
coagulation factor II, thrombin
ISO
protein:increased expression:blood plasma (human)
RGD
PMID:20699256 PMID:21866301
RGD:40818435 RGD:5147778
NCBI chr11:46,669,925...46,690,391
Ensembl chr11:47,227,891...47,249,157
G
HSPA4
heat shock protein family A (Hsp70) member 4
ISO
RGD
PMID:21801456
RGD:6218957
NCBI chr 5:128,463,186...128,517,563
Ensembl chr 5:134,619,076...134,673,658
G
IFNG
interferon gamma
ISO
RGD
PMID:10684988
RGD:10755744
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL23A
interleukin 23 subunit alpha
susceptibility
ISO
RGD
PMID:23182712
RGD:39457956
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
PRG2
proteoglycan 2, pro eosinophil major basic protein
ISO
mRNA:increased expression:plancenta (human)
RGD
PMID:29545200
RGD:40902989
NCBI chr11:52,628,289...52,631,634
Ensembl chr 3:160,118,111...160,122,002
G
SOAT1
sterol O-acyltransferase 1
ameliorates
ISO
DNA:SNP:exon: rs1044925 (human)
RGD
PMID:31236660
RGD:126925205
NCBI chr 1:154,776,305...154,840,594
Ensembl chr 1:158,464,886...158,524,909
G
VIM
vimentin
severity
ISO
protein:increased expression:plasma
RGD
PMID:22199233
RGD:6480538
NCBI chr10:17,546,389...17,554,702
Ensembl chr10:17,818,285...17,826,642
G
IL2RB
interleukin 2 receptor subunit beta
exacerbates
ISO
RGD
PMID:20460838
RGD:42724464
NCBI chr22:18,039,469...18,069,952
Ensembl chr22:35,874,898...35,899,038
G
MBL2
mannose binding lectin 2
susceptibility
ISO
DNA:polymorphisms, haplotype:promoter,exon:
RGD
PMID:19827946
RGD:12910843
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
CAT
catalase
ISO
protein:decreased activity:erythrocyte:
RGD
PMID:9892499
RGD:9479188
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL2
C-C motif chemokine ligand 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CCR1
C-C motif chemokine receptor 1
ISO
RGD
PMID:12874303
RGD:5688168
NCBI chr 3:46,107,526...46,114,229
Ensembl chr 3:47,214,688...47,215,755
G
CCR2
C-C motif chemokine receptor 2
ISO
mRNA:increased expression:foot, lymph node
RGD
PMID:12874303
RGD:5688168
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR5
C-C motif chemokine receptor 5
no_association
ISO
DNA:frameshift mutation: :p.S185_T195del (rs333) (human)
RGD
PMID:17214851 PMID:23632983
RGD:8549764 RGD:8549765
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD163
CD163 molecule
ISO
mRNA, protein:increased expression:skin of body, blood plasma, CD14-positive monocyte (human)
RGD
PMID:32023254
RGD:127345130
NCBI chr12:7,616,714...7,649,768
Ensembl chr12:7,775,343...7,810,023
G
CD274
CD274 molecule
ISO
RGD
PMID:16358363
RGD:41410801
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
G
COL1A1
collagen type I alpha 1 chain
ISO
DNA:SNPs: :rs1061237, rs2586488 (human)
RGD
PMID:25562121
RGD:11041176
NCBI chr17:44,274,349...44,291,764
Ensembl chr17:49,150,677...49,166,677
G
CXCL8
C-X-C motif chemokine ligand 8
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
FOXP3
forkhead box P3
ISO
mRNA:increased expression:Peripheral blood mononuclear cell:
RGD
PMID:29205403
RGD:38455981
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
G
IFNG
interferon gamma
treatment
ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:8154019 PMID:9234779 PMID:20102417 PMID:27999013
RGD:40890273
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism mRNA:increased expression:Peripheral blood mononuclear cell:
CTD RGD
PMID:20102417 PMID:29205403
RGD:38455981
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL13
interleukin 13
treatment
ISO
RGD
PMID:12739821 PMID:18924210
RGD:8549536 RGD:8549561
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
IL17A
interleukin 17A
ISO
mRNA:increased expression:Peripheral blood mononuclear cell:
RGD
PMID:29205403
RGD:38455981
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL23A
interleukin 23 subunit alpha
ISO
RGD
PMID:29078003
RGD:39457938
NCBI chr12:32,575,321...32,576,856
Ensembl chr12:32,828,902...32,830,617
G
IL32
interleukin 32
susceptibility ameliorates
ISO
DNA:SNPs:enhancers: (rs4786370, rs4349147) (human)
RGD
PMID:28709468 PMID:32023240
RGD:150340717 RGD:150340742
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
IL4
interleukin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20102417
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
LTA
lymphotoxin alpha
no_association
ISO
DNA:SNP:intron:252A>G (human)
RGD
PMID:16950634
RGD:8548800
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
LTB
lymphotoxin beta
ISO
RGD
PMID:17911622
RGD:8548820
NCBI chr 6:31,241,643...31,244,454
Ensembl chr 6:32,131,760...32,133,467
G
MMP2
matrix metallopeptidase 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:21091666
RGD:8657030
NCBI chr16:35,711,866...35,738,881
Ensembl chr16:54,812,694...54,844,279
G
PDCD1LG2
programmed cell death 1 ligand 2
ISO
RGD
PMID:16358363
RGD:41410801
NCBI chr 9:5,313,071...5,391,676
Ensembl chr 9:5,514,449...5,575,688
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
treatment
ISO
RGD
PMID:27999013
RGD:40890273
NCBI chr 1:8,418,570...8,495,435
Ensembl chr 1:9,686,208...9,724,633
G
SLC11A1
solute carrier family 11 member 1
ISO
DNA:insertion/deletion (human)
RGD
PMID:20089160
RGD:5684930
NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941
G
SOD1
superoxide dismutase 1
ISO
protein:increased activity:erythrocyte:
RGD
PMID:9892499
RGD:9479188
NCBI chr21:18,029,831...18,037,526
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:10458767
RGD:8661703
NCBI chr2B:78,331,402...78,549,231
Ensembl chr2B:196,247,881...196,366,011
G
TLR2
toll like receptor 2
ISO
protein:decreased expression:skin:
RGD
PMID:20493664
RGD:7794748
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TLR4
toll like receptor 4
ISO
protein:decreased expression:skin:
RGD
PMID:20493664
RGD:7794748
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TNF
tumor necrosis factor
no_association
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:-308G>A (rs1800629) (human)
CTD RGD
PMID:16950634 PMID:20102417
RGD:8548800
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16374615 PMID:29255076
RGD:14975099
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16374615
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16374615
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL2
interleukin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16374615
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL5
interleukin 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16374615
NCBI chr 5:127,955,377...127,961,726
Ensembl chr 5:134,119,608...134,121,675
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16374615
NCBI chr 7:23,415,922...23,420,767
G
NFKB1
nuclear factor kappa B subunit 1
severity
ISO
RGD
PMID:20086086
RGD:40902842
NCBI chr 4:94,925,048...95,040,849
Ensembl chr 4:105,589,062...105,704,098
G
TLR4
toll like receptor 4
ISO
RGD
PMID:15910421
RGD:7241086
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
AGER
advanced glycosylation end-product specific receptor
ISO
protein:increased expression:brain
RGD
PMID:25014011
RGD:8695986
NCBI chr 6:31,828,363...31,831,981
Ensembl chr 6:32,708,251...32,711,641
G
ARG1
arginase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21232540
NCBI chr 6:129,372,747...129,383,880
Ensembl chr 6:133,479,966...133,491,162
G
BTK
Bruton tyrosine kinase
susceptibility
ISO
RGD
PMID:28783468
RGD:124715477
NCBI chr X:90,551,874...90,588,786
Ensembl chr X:100,684,017...100,725,187
G
C3
complement C3
ISO
RGD
PMID:15378355
RGD:7401274
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:10899907
RGD:8661227
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR5
C-C motif chemokine receptor 5
disease_progression
ISO
associated with HIV Infections;protein:increased expression:blood, T cell
RGD
PMID:10553079 PMID:17457607
RGD:8551832 RGD:8551841
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17218153
NCBI chr 1:135,062,102...135,064,402
G
DUSP1
dual specificity phosphatase 1
treatment
ISO
RGD
PMID:21471446
RGD:7771536
NCBI chr 5:168,121,536...168,124,671
Ensembl chr 5:175,032,803...175,035,960
G
DUSP6
dual specificity phosphatase 6
treatment
ISO
RGD
PMID:21471446
RGD:7771536
NCBI chr12:86,875,289...86,879,731
Ensembl chr12:90,195,482...90,200,321
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:2145107 PMID:16540374 PMID:17218153
RGD:7829781
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16540374 PMID:20404924
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL18
interleukin 18
treatment
ISO
CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:10768930 PMID:16879623
RGD:8655909
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL2
interleukin 2
ISO
RGD
PMID:6224858
RGD:8693326
NCBI chr 4:114,637,328...114,642,586
Ensembl chr 4:125,782,563...125,787,984
G
IL21
interleukin 21
exacerbates
ISO
protein:increased expression:popliteal lymph node (mouse)
RGD
PMID:22429963
RGD:127285547
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
G
IL27
interleukin 27
exacerbates
ISO
RGD
PMID:25466588
RGD:126790552
G
IL4
interleukin 4
treatment
ISO
protein:increased expression:serum
RGD
PMID:2145107 PMID:2521244
RGD:7829781 RGD:7829820
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16540374
NCBI chr 7:23,415,922...23,420,767
G
ITGB2
integrin subunit beta 2
ameliorates
ISO
RGD
PMID:14502280
RGD:127285813
NCBI chr21:31,181,228...31,216,033
Ensembl chr21:44,470,999...44,505,963
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26670606
NCBI chr 1:125,918,760...125,923,952
Ensembl chr 1:129,566,827...129,572,086
G
SLC6A4
solute carrier family 6 member 4
ISO
lupoid leishmaniasis;protein:increased expression:skin of body (human)
RGD
PMID:23989888
RGD:36947873
NCBI chr17:26,546,177...26,572,301
Ensembl chr17:27,050,900...27,092,882
G
TNF
tumor necrosis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16540374
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF18
TNF receptor superfamily member 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20139272
G
TNFSF4
TNF superfamily member 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10637281
NCBI chr 1:148,684,689...148,989,775
Ensembl chr 1:152,391,450...152,415,845
G
TREM1
triggering receptor expressed on myeloid cells 1
severity
ISO
RGD
PMID:24453980
RGD:126925972
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
G
VDR
vitamin D receptor
ISO
RGD
PMID:17551101
RGD:8158083
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
G
CCL20
C-C motif chemokine ligand 20
ISO
protein:increased expression:synovial fluid
RGD
PMID:23371320
RGD:7488895
NCBI chr2B:115,052,768...115,056,479
Ensembl chr2B:233,862,505...233,866,225
G
CXCR2
C-X-C motif chemokine receptor 2
severity
ISO
RGD
PMID:12847259
RGD:7257681
NCBI chr2B:105,387,198...105,400,533
Ensembl chr2B:223,997,066...223,998,148
G
NOD2
nucleotide binding oligomerization domain containing 2
ISO
RGD
PMID:21387014
RGD:5508754
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
PLAUR
plasminogen activator, urokinase receptor
ISO
mRNA:increased expression:skin
RGD
PMID:19461880
RGD:6483813
NCBI chr19:40,588,100...40,616,479
Ensembl chr19:49,197,341...49,222,561 Ensembl chr19:49,197,341...49,222,561
G
CCL2
C-C motif chemokine ligand 2
ISO
protein:increased expression:serum (human)
RGD
PMID:16358960
RGD:11528571
NCBI chr17:22,528,154...22,530,091
Ensembl chr17:22,820,890...22,823,384
G
CD40
CD40 molecule
ISO
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:16463218
RGD:11352252
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD40LG
CD40 ligand
ISO
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:16463218
RGD:11352252
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
G
CXCL8
C-X-C motif chemokine ligand 8
treatment
ISO
RGD
PMID:24239846
RGD:39939054
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
IL1B
interleukin 1 beta
ISO
RGD
PMID:23134838
RGD:7193053
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
ABCB1
ATP binding cassette subfamily B member 1
treatment susceptibility
ISO
DNA:haplotype: :1236C>T, 2677G>T,3435C>T (human) DNA:hypermethylation:promoter DNA:SNP: :c3435C>T(human) DNA:SNPs,haplotype: :rs2032582, rs1128503 (human)
RGD
PMID:17015054 PMID:19331170 PMID:28422980 PMID:28934955
RGD:39456120 RGD:39456123 RGD:39457679 RGD:39457680
NCBI chr 7:79,497,536...79,706,277
Ensembl chr 7:93,147,950...93,243,238
G
ACE
angiotensin I converting enzyme
severity
ISO
RGD
PMID:31234939
RGD:39939120
NCBI chr17:57,556,294...57,577,294
Ensembl chr17:62,702,341...62,733,853
G
ACKR1
atypical chemokine receptor 1 (Duffy blood group)
susceptibility
ISO
ClinVar Annotator: match by term: Plasmodium vivax, resistance to
OMIM ClinVar
PMID:7663520 PMID:8547665 PMID:8651934 PMID:10570183 PMID:10791881 PMID:17304246 PMID:18179887 PMID:18621010 PMID:19180233 PMID:19620399 PMID:20932074 More...
NCBI chr 1:134,554,406...134,557,386
Ensembl chr 1:138,352,086...138,354,733
G
AICDA
activation induced cytidine deaminase
ISO
protein:increased expression: B cell
RGD
PMID:27980783
RGD:30310233
NCBI chr12:8,688,392...8,699,008
Ensembl chr12:8,904,273...8,913,917
G
ANK1
ankyrin 1
ISO
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr 8:40,897,879...41,140,290
Ensembl chr 8:38,346,503...38,588,549
G
APOE
apolipoprotein E
ISO
DNA:missense mutations:cds:p.C112R, p.C158R (human)
RGD
PMID:24116184
RGD:11039486
NCBI chr19:41,853,669...41,857,252
Ensembl chr19:50,459,906...50,463,490
G
AQP4
aquaporin 4
ISO
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr18:20,108,607...20,122,381
Ensembl chr18:23,713,146...23,726,919
G
CBS
cystathionine beta-synthase
susceptibility
ISO
DNA:insertion:cds: (844ins68) (human)
RGD
PMID:27198213
RGD:40903062
NCBI chr21:29,361,519...29,385,610
Ensembl chr21:42,670,530...42,690,932
G
CD163
CD163 molecule
exacerbates severity
ISO
protein:increased expression:blood plasma (human) protein:altered expression:blood plasma (human)
RGD
PMID:18632918 PMID:22290142
RGD:127285797 RGD:149735529
NCBI chr12:7,616,714...7,649,768
Ensembl chr12:7,775,343...7,810,023
G
CD1D
CD1d molecule
exacerbates ameliorates
ISO
RGD
PMID:12938235 PMID:24703850
RGD:127345117 RGD:127345121
NCBI chr 1:133,549,258...133,557,752
Ensembl chr 1:137,341,690...137,348,173
G
CD36
CD36 molecule
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to | ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:10890433 PMID:18305138 PMID:19403559 PMID:25741868
NCBI chr 7:72,566,478...72,643,517
Ensembl chr 7:86,265,114...86,305,865
G
CD40
CD40 molecule
severity
ISO
RGD
PMID:11485931
RGD:11352239
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD40LG
CD40 ligand
severity
ISO
RGD
PMID:11485931
RGD:11352239
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
G
CISH
cytokine inducible SH2 containing protein
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:20484391
NCBI chr 3:50,531,870...50,537,319
Ensembl chr 3:51,769,194...51,774,548
G
CR1
complement C3b/C4b receptor 1 (Knops blood group)
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, severe, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:10528197 PMID:14694201 PMID:20855594 PMID:25741868
NCBI chr 1:183,094,601...183,246,957
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:8730300
NCBI chr 1:135,062,102...135,064,402
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
disease_progression treatment
ISO
RGD
PMID:28892065
RGD:38455986
NCBI chr2B:91,054,917...91,106,234
Ensembl chr2B:209,239,417...209,244,498
G
EPHB2
EPH receptor B2
ISO
mRNA:increased expression:liver
RGD
PMID:25784101
RGD:127285023
NCBI chr 1:21,895,961...22,107,649
Ensembl chr 1:22,912,570...23,047,118
G
EPHB3
EPH receptor B3
ISO
RGD
PMID:25784101
RGD:127285023
NCBI chr 3:181,604,188...181,624,744
Ensembl chr 3:190,089,522...190,104,905
G
EPHB6
EPH receptor B6
ISO
RGD
PMID:25784101
RGD:127285023
NCBI chr 7:134,845,936...134,862,114
Ensembl chr 7:147,337,558...147,353,575
G
FCGR2A
Fc fragment of IgG receptor IIa
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, severe, susceptibility to
OMIM ClinVar
PMID:8636449 PMID:9843982 PMID:10675363 PMID:15367919 PMID:19915573 PMID:19965803 PMID:24033266 More...
NCBI chr 1:136,892,311...136,906,450
G
FCGR2B
Fc fragment of IgG receptor IIb
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, resistance to
OMIM ClinVar
PMID:12115230 PMID:15459183 PMID:16115811 PMID:16170323 PMID:17435165 PMID:20385827 More...
NCBI chr 1:137,074,342...137,090,962
Ensembl chr 1:140,882,043...140,890,637
G
FOXP3
forkhead box P3
disease_progression
ISO
RGD
PMID:16169501 PMID:19338000
RGD:38455985 RGD:38455992
NCBI chr X:41,550,462...41,567,492
Ensembl chr X:49,402,652...49,417,029
G
G6PD
glucose-6-phosphate dehydrogenase
susceptibility severity
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to | ClinVar Annotator: match by term: Plasmodium vivax, resistance to DNA:point mutation:cds:c.968T>C (human)
OMIM ClinVar RGD
PMID:5448 PMID:16832 PMID:1303173 PMID:1459579 PMID:1551674 PMID:1562739 PMID:1631957 PMID:1805484 PMID:1924316 PMID:1945893 PMID:1953767 PMID:1972698 PMID:1978554 PMID:1978555 PMID:2253938 PMID:2263506 PMID:2321910 PMID:2393028 PMID:2503817 PMID:2572288 PMID:2633878 PMID:2836867 PMID:2849540 PMID:2912069 PMID:3198117 PMID:3338798 PMID:3393536 PMID:3446582 PMID:4283789 PMID:4359638 PMID:4379606 PMID:4388132 PMID:4392654 PMID:4435794 PMID:4721339 PMID:4837298 PMID:4974311 PMID:5081671 PMID:5305539 PMID:5369703 PMID:5485383 PMID:5641629 PMID:5673160 PMID:5770172 PMID:5844610 PMID:6015571 PMID:6698555 PMID:6714986 PMID:7203486 PMID:7327562 PMID:7390473 PMID:7440223 PMID:7577654 PMID:7590755 PMID:7789945 PMID:7803800 PMID:7806085 PMID:7825590 PMID:7947239 PMID:7947250 PMID:7949118 PMID:7959686 PMID:8118045 PMID:8193373 PMID:8244337 PMID:8370579 PMID:8447319 PMID:8471773 PMID:8490627 PMID:8537082 PMID:8611726 PMID:8807321 PMID:8860013 PMID:8956035 PMID:9017974 PMID:9192788 PMID:9233561 PMID:9250351 PMID:9342374 PMID:9589612 PMID:9858856 PMID:10221015 PMID:10502785 PMID:10643148 PMID:10734064 PMID:10782016 PMID:11024211 PMID:11146567 PMID:11243133 PMID:11400791 PMID:11445808 PMID:11499668 PMID:11601226 PMID:11793482 PMID:12028056 PMID:12064920 PMID:12105841 PMID:12367584 PMID:12497642 PMID:12737938 PMID:12768444 PMID:14014720 PMID:14278484 PMID:14505231 PMID:15223006 PMID:15315792 PMID:15349799 PMID:15502081 PMID:15625830 PMID:15727905 PMID:15766741 PMID:15906717 PMID:16088936 PMID:16119988 PMID:16136268 PMID:16143877 PMID:16155737 PMID:16329560 PMID:16356170 PMID:16513531 PMID:16528451 PMID:16607506 PMID:16777444 PMID:16927025 PMID:17587269 PMID:17726510 PMID:17959407 PMID:18046504 PMID:18226470 PMID:18270558 PMID:18329300 PMID:18452027 PMID:18568599 PMID:19589177 PMID:19594365 PMID:20007901 PMID:20200584 PMID:20203002 PMID:20236109 PMID:20602793 PMID:21446359 PMID:21479984 PMID:21507207 PMID:21637675 PMID:21677401 PMID:21874587 PMID:21931771 PMID:21989994 PMID:22018328 PMID:22164279 PMID:22165289 PMID:22171972 PMID:22293322 PMID:22307442 PMID:22452742 PMID:22552160 PMID:22770933 PMID:22906047 PMID:22906837 PMID:22963789 PMID:23006493 PMID:23144702 PMID:23479361 PMID:23926329 PMID:23965028 PMID:24033266 PMID:24134566 PMID:24460025 PMID:24551785 PMID:24586352 PMID:24615128 PMID:25071003 PMID:25201310 PMID:25326637 PMID:25440321 PMID:25536053 PMID:25541721 PMID:25548459 PMID:25741868 PMID:25775246 PMID:26060661 PMID:26226515 PMID:26633385 PMID:26823837 PMID:26990548 PMID:27053284 PMID:27213370 PMID:27287612 PMID:27519946 PMID:27535533 PMID:27853304 PMID:27880809 PMID:27884173 PMID:27980749 PMID:28195434 PMID:28492532 PMID:28852037 PMID:29072585 PMID:29141760 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30077011 PMID:30096395 PMID:30161219 PMID:30314477 PMID:30315739 PMID:30674319 PMID:31489982 PMID:31525211 PMID:31862010 PMID:31863082 PMID:32180910 PMID:32425388 PMID:32860008 PMID:33051526 PMID:33072997 PMID:33413378 PMID:33636823 PMID:34620237 PMID:34659341 PMID:34762759 PMID:34895177 PMID:34934109 PMID:34966093 PMID:35313968 PMID:35840819 More...
RGD:10449115
NCBI chr X:143,972,798...143,988,960
Ensembl chr X:153,843,092...153,860,674
G
GYPA
glycophorin A (MNS blood group)
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr 4:136,455,397...136,486,858
Ensembl chr 4:147,987,750...148,019,005 Ensembl chr 4:147,987,750...148,019,005
G
GYPB
glycophorin B (MNS blood group)
susceptibility
ISO
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr 4:136,335,881...136,359,518
G
GYPC
glycophorin C (Gerbich blood group)
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, resistance to
OMIM ClinVar
PMID:1991173 PMID:5011657 PMID:8157284 PMID:11719395 PMID:12469115 PMID:21061946 More...
NCBI chr2B:33,578,851...33,619,869
G
HMOX1
heme oxygenase 1
ISO
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
ICAM1
intercellular adhesion molecule 1
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to | ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:9259284 PMID:9861406 PMID:10417733 PMID:10699175 PMID:23609612 PMID:25741868 More...
NCBI chr19:9,821,402...9,837,021
Ensembl chr19:10,484,414...10,500,605
G
IFNG
interferon gamma
ISO
OMIM:609148 | OMIM:611162
MouseDO
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IKBKG
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to
ClinVar
PMID:1945893 PMID:3198117 PMID:7803800 PMID:8244337 PMID:8471773 PMID:9589612 PMID:10502785 PMID:11601226 PMID:12064920 PMID:15727905 PMID:16329560 PMID:16607506 PMID:25741868 PMID:28492532 PMID:29300386 PMID:29339739 PMID:30045279 PMID:30315739 PMID:31489982 PMID:31863082 PMID:33051526 PMID:33072997 PMID:34659341 PMID:34762759 PMID:34895177 PMID:35313968 PMID:35840819 More...
NCBI chr X:143,988,720...144,010,078
Ensembl chr X:153,854,493...153,876,092
G
IL21
interleukin 21
exacerbates
ISO
RGD
PMID:25763578
RGD:127285358
NCBI chr 4:114,795,979...114,806,936
Ensembl chr 4:125,943,495...125,951,915
G
IL27
interleukin 27
ameliorates
ISO
RGD
PMID:24522137 PMID:26968425
RGD:11530371 RGD:126790512
G
IL33
interleukin 33
ISO
protein:increased expression:serum:
RGD
PMID:28359899
RGD:39938859
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
G
LTBR
lymphotoxin beta receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:15788153
NCBI chr12:6,514,432...6,521,966
Ensembl chr12:6,422,470...6,438,510
G
MAPKAPK3
MAPK activated protein kinase 3
ISO
ClinVar Annotator: match by term: Malaria, susceptibility to
ClinVar
PMID:20484391
NCBI chr 3:50,542,547...50,574,817
Ensembl chr 3:51,779,912...51,812,124
G
MKI67
marker of proliferation Ki-67
ISO
associated with Lung Neoplasms
RGD
PMID:21931708
RGD:6483517
NCBI chr10:124,684,336...124,714,143
Ensembl chr10:128,936,037...128,962,555
G
NCR3
natural cytotoxicity triggering receptor 3
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, severe, susceptibility to
OMIM ClinVar
PMID:17208487
NCBI chr 6:31,249,947...31,281,613
Ensembl chr 6:32,139,981...32,171,525
G
NOS2
nitric oxide synthase 2
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, resistance to | ClinVar Annotator: match by term: Malaria, severe, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:9457101 PMID:12433515 PMID:31995689
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
PKLR
pyruvate kinase L/R
susceptibility
ISO
DNA:missense mutation:cds:p.I90N (mouse) OMIM:609148 | OMIM:611162 DNA:mutations, haplotype:multiple (human)
RGD MouseDO
PMID:14595440 PMID:20377593
RGD:11535999 RGD:11537407
NCBI chr 1:130,634,111...130,646,644
Ensembl chr 1:134,239,565...134,251,351
G
PRF1
perforin 1
ISO
RGD
PMID:21525386
RGD:6482803
NCBI chr10:67,071,141...67,078,057
Ensembl chr10:69,597,574...69,603,070
G
PROCR
protein C receptor
disease_progression
ISO
RGD
PMID:27671831
RGD:126848795
NCBI chr20:31,500,838...31,543,928
Ensembl chr20:32,622,876...32,628,320
G
SLC19A1
solute carrier family 19 member 1
ISO
DNA:SNP::g.80G>A (human)
RGD
PMID:27198213
RGD:40903062
NCBI chr21:31,836,774...31,883,829
Ensembl chr21:45,090,595...45,134,752
G
SLC4A1
solute carrier family 4 member 1 (Diego blood group)
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, cerebral, resistance to | ClinVar Annotator: match by term: Malaria, susceptibility to
OMIM ClinVar
PMID:1378323 PMID:1722314 PMID:1737855 PMID:2146504 PMID:6338046 PMID:7689982 PMID:7919393 PMID:7949112 PMID:8434259 PMID:8704215 PMID:9207478 PMID:9312167 PMID:9854053 PMID:10403343 PMID:10926824 PMID:10942416 PMID:12087557 PMID:12750988 PMID:12938018 PMID:14618420 PMID:16107207 PMID:16420521 PMID:17215882 PMID:18266205 PMID:19229254 PMID:19289107 PMID:19625994 PMID:20068363 PMID:20151848 PMID:20421175 PMID:20799361 PMID:22126643 PMID:22518001 PMID:22609520 PMID:23255290 PMID:24652967 PMID:25741868 PMID:28045035 PMID:28188436 PMID:28233610 PMID:28492532 PMID:28542241 PMID:29627839 PMID:30192042 PMID:30230413 PMID:31147440 PMID:31672324 PMID:31959358 PMID:32071839 PMID:33532864 PMID:35738466 More...
NCBI chr17:13,131,851...13,150,872
Ensembl chr17:13,302,796...13,317,312
G
SPP1
secreted phosphoprotein 1
ISO
RGD
PMID:16552072
RGD:1581333
NCBI chr 4:80,263,711...80,271,466
Ensembl chr 4:90,988,200...90,995,935
G
TBX21
T-box transcription factor 21
ISO
RGD
PMID:19338000
RGD:38455985
NCBI chr17:9,791,008...9,803,894
Ensembl chr17:9,973,920...9,985,660
G
TIRAP
TIR domain containing adaptor protein
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, resistance to
OMIM ClinVar
PMID:16991088 PMID:17322885 PMID:18305471 PMID:25741868
NCBI chr11:121,100,558...121,112,844
Ensembl chr11:125,018,064...125,022,309
G
TNF
tumor necrosis factor
susceptibility
ISO
ClinVar Annotator: match by term: Malaria, cerebral, susceptibility to
OMIM ClinVar
PMID:8056188 PMID:9818939 PMID:10369255 PMID:10450718 PMID:11261930 PMID:11506397 PMID:11826025 PMID:11896460 PMID:12485196 PMID:12746914 PMID:12759288 PMID:14681301 PMID:14718719 PMID:16418737 PMID:16720636 PMID:16865291 PMID:16909270 PMID:18050183 PMID:18713756 PMID:19365401 PMID:22760475 PMID:22992668 More...
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TREM1
triggering receptor expressed on myeloid cells 1
severity
ISO
RGD
PMID:27671831
RGD:126848795
NCBI chr 6:40,861,283...40,874,446
Ensembl chr 6:42,163,337...42,183,091
G
TSLP
thymic stromal lymphopoietin
ISO
mRNA:altered expression:multiple (mouse)
RGD
PMID:28955823
RGD:38596344
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
SLC4A1
solute carrier family 4 member 1 (Diego blood group)
severity
ISO
DNA:snp:promoter:g.-5699T>C (human)
RGD
PMID:16960783
RGD:10450507
NCBI chr17:13,131,851...13,150,872
Ensembl chr17:13,302,796...13,317,312
G
IFNG
interferon gamma
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:7854095
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
LTA
lymphotoxin alpha
ISO
DNA:polymorphism:intron
RGD
PMID:7595196
RGD:8548799
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
TNF
tumor necrosis factor
ISO
DNA:SNP:promoter:-308G>A (human)
RGD
PMID:7595196
RGD:8548799
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
ANXA1
annexin A1
ISO
RGD
PMID:22740770
RGD:7421536
NCBI chr 9:51,647,404...51,665,990
Ensembl chr 9:71,929,728...71,948,779
G
IL10
interleukin 10
ISO
RGD
PMID:19026704
RGD:7365028
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL17A
interleukin 17A
treatment
ISO
protein:increased expression:aqueous humor (human)
RGD
PMID:22927448
RGD:8698652
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL27
interleukin 27
disease_progression
ISO
mRNA:increased expression:eye, cervical lymph node (mouse)
RGD
PMID:29779048
RGD:126790500
G
NOD2
nucleotide binding oligomerization domain containing 2
susceptibility
ISO
DNA:snp:3' utr:g.*397A>C (rs3135499)(human)
RGD
PMID:23100559
RGD:8547527
NCBI chr16:30,955,976...30,995,451
Ensembl chr16:49,837,891...49,873,773
G
ABO
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
susceptibility
ISO
DNA:SNPs,haplotype:multiple
RGD
PMID:18003641
RGD:39938831
NCBI chr 9:104,354,115...104,399,057
Ensembl chr 9:132,989,574...133,010,324
G
ADAMTS13
ADAM metallopeptidase with thrombospondin type 1 motif 13
ISO
protein:decreased activity:plasma (human)
RGD
PMID:20062916
RGD:10449041
NCBI chr 9:104,541,051...104,582,574
Ensembl chr 9:133,156,761...133,193,707
G
CAST
calpastatin
ISO
protein:alter localization:erythrocyte
RGD
PMID:17359359
RGD:5509812
NCBI chr 5:91,972,572...92,084,657
Ensembl chr 5:97,527,071...97,636,650
G
CLEC11A
C-type lectin domain containing 11A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19884328
NCBI chr19:47,682,806...47,690,389
Ensembl chr19:56,586,183...56,588,580
G
CR1
complement C3b/C4b receptor 1 (Knops blood group)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:9230440 PMID:11724985
NCBI chr 1:183,094,601...183,246,957
G
CYP2C19
cytochrome P450 family 2 subfamily C member 19
treatment
ISO
DNA:polymorphisms::
RGD
PMID:10471063
RGD:124713538
NCBI chr10:91,375,255...91,465,215
Ensembl chr10:94,884,472...94,970,065
G
FAS
Fas cell surface death receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21625619
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FCGR2A
Fc fragment of IgG receptor IIa
severity
ISO
DNA:missense mutation:cds:p.R131H (rs1801274) (human)
RGD
PMID:18194515
RGD:5147927
NCBI chr 1:136,892,311...136,906,450
G
G6PD
glucose-6-phosphate dehydrogenase
severity
ISO
DNA:missense mutation:cds:202G>A (p.V68M) (human)
RGD
PMID:24943486
RGD:10449113
NCBI chr X:143,972,798...143,988,960
Ensembl chr X:153,843,092...153,860,674
G
GSTP1
glutathione S-transferase pi 1
severity
ISO
RGD
PMID:19635899
RGD:10450848
NCBI chr11:62,942,756...62,945,701
Ensembl chr11:66,253,421...66,256,472
G
IL13
interleukin 13
ISO
protein:increased expression:plasma
RGD
PMID:21985368
RGD:5684362
NCBI chr 5:128,073,863...128,078,453
Ensembl chr 5:134,235,788...134,240,548
G
LOC100972994
HLA class II histocompatibility antigen, DQ beta 1 chain
susceptibility
ISO
DNA:polymorphism:cds:HLA-DQB1*0501 (human)
RGD
PMID:11076705
RGD:11041780
NCBI chr 6:32,237,395...32,244,201
Ensembl chr 6:33,353,599...33,360,272
G
MBL2
mannose binding lectin 2
susceptibility
ISO
DNA:haplotype:exon:
RGD
PMID:18396436
RGD:11530064
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
TNF
tumor necrosis factor
severity
ISO
protein:increased expression:plasma
RGD
PMID:1984482
RGD:10450571
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
ACKR1
atypical chemokine receptor 1 (Duffy blood group)
ISO
ClinVar Annotator: match by term: Resistance to Plasmodium vivax infection
OMIM ClinVar
PMID:7663520 PMID:8547665 PMID:8651934 PMID:10570183 PMID:10791881 PMID:17304246 PMID:18179887 PMID:18621010 PMID:19180233 PMID:19620399 PMID:20932074 More...
NCBI chr 1:134,554,406...134,557,386
Ensembl chr 1:138,352,086...138,354,733
G
IL10
interleukin 10
ISO
RGD
PMID:24717969
RGD:11041890
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
NOS2
nitric oxide synthase 2
ISO
protein:altered activity:brain, peritoneal macrophage
RGD
PMID:20169057
RGD:4891375
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
TSLP
thymic stromal lymphopoietin
susceptibility
ISO
protein:increased expression:serum (mouse)
RGD
PMID:28769924
RGD:38549587
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
RAPGEF3
Rap guanine nucleotide exchange factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24218580
NCBI chr12:40,974,756...40,999,471
Ensembl chr12:41,848,785...41,873,252
G
CD40
CD40 molecule
ISO
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:16463218
RGD:11352252
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD40LG
CD40 ligand
ISO
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:16463218
RGD:11352252
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
G
BAX
BCL2 associated X, apoptosis regulator
ISO
RGD
PMID:24812878
RGD:10054127
NCBI chr19:45,955,926...45,962,870
Ensembl chr19:54,793,594...54,800,468
G
IL27
interleukin 27
susceptibility
ISO
RGD
PMID:22981537 PMID:31548322
RGD:126790501 RGD:126790522
G
NFKBIA
NFKB inhibitor alpha
exacerbates
ISO
human gene in a mouse model
RGD
PMID:12626571
RGD:126925984
NCBI chr14:16,155,331...16,158,588
G
UCP2
uncoupling protein 2
susceptibility
ISO
RGD
PMID:11101840
RGD:737759
NCBI chr11:69,047,397...69,056,056
Ensembl chr11:72,354,529...72,363,185
G
ADA
adenosine deaminase
ISO
RGD
PMID:20809996
RGD:5128861
NCBI chr20:40,950,238...40,982,481
Ensembl chr20:42,044,613...42,076,868
G
BCHE
butyrylcholinesterase
ISO
protein:decreased expression:plasma
RGD
PMID:20138875
RGD:5687328
NCBI chr 3:162,794,184...162,858,574
Ensembl chr 3:170,845,494...170,911,481
G
CD1D
CD1d molecule
exacerbates
ISO
RGD
PMID:15731095
RGD:127345115
NCBI chr 1:133,549,258...133,557,752
Ensembl chr 1:137,341,690...137,348,173
G
CXCL8
C-X-C motif chemokine ligand 8
disease_progression
ISO
protein:increased expression:cerebrospinal fluid (human)
RGD
PMID:25375156
RGD:150521552
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
IL4
interleukin 4
treatment
ISO
RGD
PMID:24731531
RGD:10402804
NCBI chr 5:128,091,342...128,099,886
Ensembl chr 5:134,253,039...134,261,581
G
PRF1
perforin 1
ISO
RGD
PMID:19651871
RGD:6482814
NCBI chr10:67,071,141...67,078,057
Ensembl chr10:69,597,574...69,603,070
G
AICDA
activation induced cytidine deaminase
ISO
RGD
PMID:31001826
RGD:32716386
NCBI chr12:8,688,392...8,699,008
Ensembl chr12:8,904,273...8,913,917
G
CCR2
C-C motif chemokine receptor 2
ISO
RGD
PMID:24818662
RGD:8661728
NCBI chr 3:46,255,725...46,263,285
Ensembl chr 3:47,361,124...47,368,312
G
CCR3
C-C motif chemokine receptor 3
ISO
protein:increased expression:blood, T cell
RGD
PMID:15379987
RGD:6893393
NCBI chr 3:46,147,928...46,172,947
Ensembl chr 3:47,253,878...47,278,630
G
CCR5
C-C motif chemokine receptor 5
treatment
ISO
RGD
PMID:24617012
RGD:14401738
NCBI chr 3:46,273,096...46,278,471
Ensembl chr 3:47,380,321...47,381,379
G
CD163
CD163 molecule
exacerbates
ISO
protein:increased expression:blood serum (human)
RGD
PMID:28355218
RGD:127345133
NCBI chr12:7,616,714...7,649,768
Ensembl chr12:7,775,343...7,810,023
G
CD40
CD40 molecule
treatment
ISO
RGD
PMID:14573667
RGD:8547750
NCBI chr20:42,455,711...42,467,139
Ensembl chr20:43,541,619...43,552,994
G
CD40LG
CD40 ligand
ISO
RGD
PMID:14573667
RGD:8547750
NCBI chr X:125,776,138...125,788,820
Ensembl chr X:136,042,849...136,058,202
G
CRP
C-reactive protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:10467834
NCBI chr 1:135,062,102...135,064,402
G
CSF2
colony stimulating factor 2
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:8035028 PMID:17404324
RGD:10449527
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
mRNA:increased expression:liver
RGD
PMID:16239557
RGD:27095947
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
G
CXCL8
C-X-C motif chemokine ligand 8
treatment susceptibility
ISO
CTD Direct Evidence: marker/mechanism DNA:SNP:promoter:g.-251A>T (human)
CTD RGD
PMID:22461696 PMID:25821028 PMID:32984951
RGD:150523789 RGD:150523791
NCBI chr 4:50,452,857...50,456,015
Ensembl chr 4:56,286,708...56,288,083
G
HMOX1
heme oxygenase 1
treatment
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22461696 PMID:23729024
RGD:42724459
NCBI chr22:16,388,368...16,401,289
Ensembl chr22:34,230,825...34,244,063
G
IFNG
interferon gamma
treatment
ISO
CTD Direct Evidence: therapeutic
CTD RGD
PMID:1901333 PMID:3104456 PMID:7854095 PMID:27999013
RGD:40890273 RGD:8158041
NCBI chr12:65,663,764...65,668,732
Ensembl chr12:68,448,861...68,453,829
G
IL10
interleukin 10
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15716043 PMID:17404324 PMID:22461696 PMID:29745990
RGD:14975172
NCBI chr 1:182,369,234...182,374,207
Ensembl chr 1:186,648,289...186,653,371
G
IL10RA
interleukin 10 receptor subunit alpha
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:15716043
NCBI chr11:112,820,445...112,835,603
Ensembl chr11:116,752,619...116,767,771
G
IL18
interleukin 18
susceptibility
ISO
RGD
PMID:16879623
RGD:8655922
NCBI chr11:107,024,376...107,045,194
Ensembl chr11:110,867,586...110,888,371
G
IL1B
interleukin 1 beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17404324
NCBI chr2A:89,216,313...89,223,358
Ensembl chr2A:113,846,306...113,853,424
G
IL27
interleukin 27
ISO
mRNA, protein:increased expression:spleen, liver (mouse)
RGD
PMID:27245409
RGD:126790520
G
IL2RB
interleukin 2 receptor subunit beta
susceptibility
ISO
DNA:polymorphisms:exon:8777, 8838(human)
RGD
PMID:17108990
RGD:42724466
NCBI chr22:18,039,469...18,069,952
Ensembl chr22:35,874,898...35,899,038
G
IL32
interleukin 32
ameliorates
ISO
human gene in a mouse model
RGD
PMID:29483288
RGD:150340719
NCBI chr16:2,007,018...2,023,757
Ensembl chr16:3,179,637...3,203,929
G
IL6
interleukin 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:7554475 PMID:17404324 PMID:22461696
NCBI chr 7:23,415,922...23,420,767
G
IRF5
interferon regulatory factor 5
ISO
protein:increased expression:CD4 T cell, nucleus
RGD
PMID:30067973 PMID:32038622
RGD:40924560 RGD:40924629
NCBI chr 7:120,889,752...120,902,096
Ensembl chr 7:133,415,170...133,426,356
G
LTA
lymphotoxin alpha
severity
ISO
DNA:polymorphisms
RGD
PMID:12438370 PMID:15579454
RGD:8548784 RGD:8548789
NCBI chr 6:31,233,411...31,235,409
Ensembl chr 6:32,123,353...32,125,375
G
LTB
lymphotoxin beta
ISO
RGD
PMID:12115620
RGD:8548822
NCBI chr 6:31,241,643...31,244,454
Ensembl chr 6:32,131,760...32,133,467
G
MBL2
mannose binding lectin 2
disease_progression susceptibility
ISO
DNA:polymorphism:promoter: DNA:SNPs,haplotype:promoter,exon: protein:increased expression:serum:
RGD
PMID:17357060 PMID:22995279 PMID:26297290
RGD:11522692 RGD:8693721 RGD:8693726
NCBI chr10:49,401,364...49,409,328
Ensembl chr10:51,527,758...51,543,432
G
NFE2L2
NFE2 like bZIP transcription factor 2
treatment
ISO
RGD
PMID:23729024
RGD:42724459
NCBI chr2B:64,509,446...64,544,600
Ensembl chr2B:182,214,116...182,248,085
G
PIK3CD
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
treatment
ISO
RGD
PMID:27999013
RGD:40890273
NCBI chr 1:8,418,570...8,495,435
Ensembl chr 1:9,686,208...9,724,633
G
SLC11A1
solute carrier family 11 member 1
ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:17067929
RGD:5684944
NCBI chr2B:105,640,613...105,655,524
Ensembl chr2B:224,238,284...224,252,941
G
STAT4
signal transducer and activator of transcription 4
ISO
RGD
PMID:24242758
RGD:8661696
NCBI chr2B:78,331,402...78,549,231
Ensembl chr2B:196,247,881...196,366,011
G
TLR2
toll like receptor 2
disease_progression
ISO
RGD
PMID:23589575
RGD:15090808
NCBI chr 4:146,024,653...146,091,388
Ensembl chr 4:157,866,977...157,869,331
G
TNF
tumor necrosis factor
severity
ISO
DNA:polymorphisms CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:1901333 PMID:12438370 PMID:15579454 PMID:22461696
RGD:8548784 RGD:8548789
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all